The Max Planck Society is at the forefront of scientific research, particularly in the fields of metabolism, genetics, and artificial intelligence. Researchers at the Max Planck Institute for Metabolic Research are investigating the mechanisms by which obesity leads to insulin resistance, a precursor to diabetes, which affects millions in Europe. Their studies delve into the metabolic processes that occur in the brain when individuals experience hunger, revealing that the regulation of sugar metabolism begins in the brain. This research is crucial for understanding the increasing rates of obesity and its health implications.

In addition to metabolic research, the Max Planck Society is heavily involved in technology transfer through its subsidiary, Max-Planck-Innovation. This organization facilitates the commercialization of scientific discoveries, particularly in the biomedical and chemical-physical sectors. It supports researchers in patenting their inventions and launching startups based on Max Planck technologies, thereby bridging the gap between fundamental research and practical applications. This initiative not only promotes the utilization of scientific knowledge but also contributes to job creation and economic growth in Germany.

Germany

The Max Planck Institute of Quantum Optics is a forefront research organizations in the fields of quantum physics and photonics, with light-matter interaction at its core. 

In five different research areas excellent scientists from all corners of the world are working together in an open and diverse environment, breaking the ground to what could become another revolution in science. 

Our laboratories are amongst the best equipped in the world and our scientific culture and spirit is based on freedom and trust, both allowing our scientists to reach the most ambitious objectives.


Max Planck Society

Company Details